Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
    « Previous Issue | Next Issue »
  Cover Image

Volume 25, Issue 4; April 1, 2005

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

 

EditorialsBack

Inorganic Pyrophosphate: A Paracrine Regulator of Vascular Calcification and Smooth Muscle Phenotype

Dwight A. Towler
Arterioscler Thromb Vasc Biol. 2005;25:651-654, doi:10.1161/01.ATV.0000158943.79580.9d.
Full Text | PDF  

When Interleukin-18 Conducts, the Preludio Sounds the Same no Matter Who Plays

Giuseppina Caligiuri, Srini Kaveri, and Antonino Nicoletti
Arterioscler Thromb Vasc Biol. 2005;25:655-657, doi:10.1161/01.ATV.0000154921.49792.ef.
Full Text | PDF  

 

Special ArticleBack

Barry S. Coller
Arterioscler Thromb Vasc Biol. 2005;25:658-670; published online before print January 20 2005, doi:10.1161/01.ATV.0000156877.94472.a5.
Abstract | Full Text | PDF
This article reviews the epidemiological evidence of an association between leukocytosis and increased morbidity and mortality from ischemic vascular disease, focusing on whether the data are consistent with a causal role for leukocytes in vascular events. It then discusses whether the existing data justify selectively entering to lower the leukocyte count.  

 

Brief ReviewsBack

David D. Gutterman, Hiroto Miura, and Yanping Liu
Arterioscler Thromb Vasc Biol. 2005;25:671-678; published online before print February 10 2005, doi:10.1161/01.ATV.0000158497.09626.3b.
Abstract | Full Text | PDF
Opening of potassium channels on vascular smooth muscle cells with resultant hyperpolarization plays a central role in several mechanisms of vasodilation. Disease states such as coronary atherosclerosis and its risk factors are associated with elevated levels of reactive oxygen (ROS) and nitrogen species that have well-defined inhibitory effects on nitric oxide-mediated vasodilation. Depending on the oxidative species, ROS can activate, inhibit, or leave unaltered potassium channel function in blood vessels. Therefore, discerning the activity of enzymes regulating production or degradation of ROS is important when assessing tissue perfusion in health and disease.  

Kenneth K. Wu, Jun-Yang Liou, and Katarzyna Cieslik
Arterioscler Thromb Vasc Biol. 2005;25:679-685; published online before print January 27 2005, doi:10.1161/01.ATV.0000157899.35660.61.
Abstract | Full Text | PDF
Cyclooxygenase-2 (COX-2) is a highly inducible enzyme exerting diverse actions on cell functions, including proliferation, migration, and DNA damage. Enhanced COX-2 expression may be protective, but excessive expression may be harmful, causing inflammation, atheromatous plaque instability, and intimal hyperplasia. In this review, the role of C/EBP in regulating COX-2 transcription is highlighted.  

 

Vascular BiologyBack

Kristen Johnson, Monika Polewski, Deborah van Etten, and Robert Terkeltaub
Arterioscler Thromb Vasc Biol. 2005;25:686-691; published online before print December 29 2004, doi:10.1161/01.ATV.0000154774.71187.f0.
Abstract | Full Text | PDF
Human "idiopathic" infantile arterial media calcification is linked to deficient PPi-generating PC-1/nucleotide pyrophosphatase phosphodiesterase 1 (NPP1). We demonstrate that NPP1 and extracellular PPi deficiencies promote chondrogenic differentiation in mesenchymal precursors and vascular smooth muscle cells. Therefore, NPP1 and PPi deficiencies promote active rather than simply dystrophic artery calcification, mediated partly by primary alterations in cell differentiation.  

Daniela Galli, Anna Innocenzi, Lidia Staszewsky, Lucia Zanetta, Maurilio Sampaolesi, Antonio Bai, Elena Martinoli, Eleonora Carlo, Giovanna Balconi, Fabio Fiordaliso, Stefano Chimenti, Gabriella Cusella, Elisabetta Dejana, Giulio Cossu, and Roberto Latini
Arterioscler Thromb Vasc Biol. 2005;25:692-697; published online before print January 20 2005, doi:10.1161/01.ATV.0000156402.52029.ce.
Abstract | Full Text | PDF | Data Supplement
Mesoangioblasts (Mabs), vessel-associated stem cells, were compared with bone marrow progenitor cells (BMPCs), fibroblasts, and embryonic stem cell-derived endothelial cells in their ability to ameliorate cardiac function after infarction, aiming to identify putative cellular mechanisms. Mabs appeared as effective as BMPCs in reducing postinfarction damage, likely through production of antiapoptotic and angiogenic factors.  

Nicolle Kränkel, Volker Adams, Axel Linke, Stephan Gielen, Sandra Erbs, Karsten Lenk, Gerhard Schuler, and Rainer Hambrecht
Arterioscler Thromb Vasc Biol. 2005;25:698-703; published online before print January 20 2005, doi:10.1161/01.ATV.0000156401.04325.8f.
Abstract | Full Text | PDF
In circulating progenitor cells (CPC), hyperglycemia induces cell-cycle arrest, impaired NO synthesis, and decreased migrational and integrative capacity. These mechanisms might contribute to the decline of CPC amount and function in diabetes mellitus.  

Ivica Grgic, Ines Eichler, Philipp Heinau, Han Si, Susanne Brakemeier, Joachim Hoyer, and Ralf Köhler
Arterioscler Thromb Vasc Biol. 2005;25:704-709; published online before print January 20 2005, doi:10.1161/01.ATV.0000156399.12787.5c.
Abstract | Full Text | PDF
We tested whether Ca2+-activated K+ (KCa) channels contribute to endothelial cell (EC) proliferation induced by proangiogenic factors. Angiogenic factors augmented mRNA expression and function of intermediate-conductance KCa channel (IKCa1). EC proliferation in vitro and angiogenesis in vivo was abolished by IKCa1 blockers, which might be of therapeutic value to prevent tumor angiogenesis.  

Hideyuki Migita and John Morser
Arterioscler Thromb Vasc Biol. 2005;25:710-716; published online before print January 20 2005, doi:10.1161/01.ATV.0000156482.76228.d1.
Abstract | Full Text | PDF
15-Deoxy-{Delta}12,14-PG J2 (15d-PGJ2) inhibits proinflammatory gene expression, but its signaling mechanisms remain unclear. Because retinoic acid receptor-related orphan receptor-{alpha} (ROR{alpha}) suppresses proinflammatory gene expression, we hypothesized that 15d-PGJ2 induces ROR{alpha} expression, resulting in inhibition of proinflammatory gene expression. Our results provide a novel insight into anti-inflammatory actions of 15d-PGJ2.  

Lambertus van Tits, Jacqueline de Graaf, Helga Toenhake, Waander van Heerde, and Anton Stalenhoef
Arterioscler Thromb Vasc Biol. 2005;25:717-722; published online before print February 3 2005, doi:10.1161/01.ATV.0000157979.51673.2c.
Abstract | Full Text | PDF
We investigated interactions of C-reactive protein (CRP), annexin A5, and low-density lipoprotein (LDL) with U937 cells. CRP binds to oxidized LDL, and via subsequent interaction with Fc{gamma} receptors it enhances binding of the particle to U937 cells. Annexin A5 also binds to oxidized LDL but does not interfere with CRP.  

Einar E. Eriksson, Eva Karlof, Karin Lundmark, Pierre Rotzius, Ulf Hedin, and Xun Xie
Arterioscler Thromb Vasc Biol. 2005;25:723-728; published online before print January 27 2005, doi:10.1161/01.ATV.0000157578.51417.6f.
Abstract | Full Text | PDF | Data Supplement
The inflammatory capacity of large vein endothelium is unclear. Here, we show that endothelium in the mouse IVC holds powerful inflammatory properties that are equally potent as that in postcapillary venules and distinct from that in arteries. The data emphasize the endothelium as target for treatment of vein disease.  

Georg Ostermann, Line Fraemohs, Thomas Baltus, Andreas Schober, Michael Lietz, Alma Zernecke, Elisa A. Liehn, and Christian Weber
Arterioscler Thromb Vasc Biol. 2005;25:729-735; published online before print January 27 2005, doi:10.1161/01.ATV.0000157154.14474.3b.
Abstract | Full Text | PDF
We studied the effect of soluble JAM-A (sJAM-A.Fc) on atherogenic recruitment of mononuclear cells. Because sJAM-A.Fc can inhibit distinct steps of mononuclear cell recruitment, ie, adhesion and transendothelial chemotaxis, on inflamed and atherosclerotic endothelium, our data suggest a functional contribution of JAM-A to atherogenesis.  

Veronica A. Carroll, Leonid L. Nikitenko, Roy Bicknell, and Adrian L. Harris
Arterioscler Thromb Vasc Biol. 2005;25:736-741; published online before print February 3 2005, doi:10.1161/01.ATV.0000157980.15710.2b.
Abstract | Full Text | PDF | Data Supplement
In this study, we report that wound healing and angiogenesis are compromised with the fibrinolytic drug, Reteplase, and show that these effects are critically dependent on the kringle 2 domain. These data provide new mechanistic insights into the bleeding complications that can occur in some patients with this drug.  

Kyung-Woo Park, Dae-Hee Kim, Hyun-Jung You, Jung-Ju Sir, Soo-In Jeon, Seock-Won Youn, Han-Mo Yang, Carsten Skurk, Young-Bae Park, Kenneth Walsh, and Hyo-Soo Kim
Arterioscler Thromb Vasc Biol. 2005;25:742-747; published online before print January 20 2005, doi:10.1161/01.ATV.0000156288.70849.26.
Abstract | Full Text | PDF
The role of FKHRL1 (forkhead transcription factor in rhabdomyosarcoma like-1) in VSMC biology and in neointimal hyperplasia after balloon angioplasty has not been studied. Here, we show that the inactivation of the forkhead transcription factor is required for neointimal hyperplasia after angioplasty, and that overexpression of FKHRL1 leads to the induction of p27 resulting in inhibition of neointimal hyperplasia.  

Rainer Wessely, Jörg Hausleiter, Cornelia Michaelis, Birgit Jaschke, Michael Vogeser, Stefan Milz, Boris Behnisch, Thomas Schratzenstaller, Magdalena Renke-Gluszko, Michael Stöver, Erich Wintermantel, Adnan Kastrati, and Albert Schömig
Arterioscler Thromb Vasc Biol. 2005;25:748-753; published online before print January 27 2005, doi:10.1161/01.ATV.0000157579.52566.ee.
Abstract | Full Text | PDF
In-stent neointima formation can be successfully attenuated by drug-eluting stents. We introduce a novel conceptual approach for stent-coating that allows for dose-adjustable, on-site stent coating process if desired with multiple compounds. Microporous stents coated with rapamycin proved safe and effective for the limitation of neointima formation in a porcine coronary stent model.  

Thomas W. Johnson, Yin Xiong Wu, Christian Herdeg, Andreas Baumbach, Andrew C. Newby, Karl R. Karsch, and Martin Oberhoff
Arterioscler Thromb Vasc Biol. 2005;25:754-759; published online before print January 27 2005, doi:10.1161/01.ATV.0000157582.33180.a9.
Abstract | Full Text | PDF
We developed eluting-stent technology to deliver an adenovirus capable of TIMP-3 overexpression and investigated its effect on restenosis. The technology resulted in effective in vitro and in vivo transduction. TIMP-3 overexpression increased apoptosis and reduced neointimal formation. Our results demonstrate for the first time to our knowledge the feasibility of adenovirus-eluting stent technology.  

T. Nakazawa, T. Chiba, E. Kaneko, K. Yui, M. Yoshida, and K. Shimokado
Arterioscler Thromb Vasc Biol. 2005;25:760-765; published online before print February 3 2005, doi:10.1161/01.ATV.0000158307.66945.b4.
Abstract | Full Text | PDF
Insulin is antiapoptotic for cultured vascular smooth muscle, but it is not clear whether insulin is antiapoptotic in vivo. We report here that insulin is antiapoptotic in vitro and in vivo. Decreased insulin action on the artery may cause unstable plaque formation in diabetes by increasing smooth muscle apoptosis.  

Takako Fujiki, Hiroaki Shimokawa, Keiko Morikawa, Hiroshi Kubota, Makoto Hatanaka, M.A. Hassan Talukder, Tetsuya Matoba, Akira Takeshita, and Kenji Sunagawa
Arterioscler Thromb Vasc Biol. 2005;25:766-771; published online before print February 10 2005, doi:10.1161/01.ATV.0000158498.19027.75.
Abstract | Full Text | PDF
This study was designed to examine the involvement of H2O2/EDHF in the effect of an ACE inhibitor in mice. The results showed that endothelium-derived H2O2 is involved in the enhancing effect of temocapril on EDHF-mediated responses in control but not in eNOS-/- mice, thus further supporting our H2O2 theory.  

Nicholas L.M. Cruden, George H. Tse, Keith A.A. Fox, Christopher A. Ludlam, Ian Megson, and David E. Newby
Arterioscler Thromb Vasc Biol. 2005;25:772-777; published online before print January 27 2005, doi:10.1161/01.ATV.0000157157.78822.25.
Abstract | Full Text | PDF
In contrast to bradykinin, intra-brachial Lys-des-Arg9-bradykinin (B1 agonist) and Lys-[Leu8]-des-Arg9-bradykinin (B1 antagonist) had no effect on vascular tone or tissue plasminogen activator release in patients with heart failure treated with angiotensin-converting enzyme inhibition. The B1 kinin receptor does not have a major vasomotor or fibrinolytic role in patients with heart failure.  

A.M.W. Spijkerman, Y.M. Smulders, P.J. Kostense, R.M.A. Henry, A. Becker, T. Teerlink, C. Jakobs, J.M. Dekker, G. Nijpels, R.J. Heine, L.M. Bouter, and C.D.A. Stehouwer
Arterioscler Thromb Vasc Biol. 2005;25:778-784; published online before print February 3 2005, doi:10.1161/01.ATV.0000157981.57694.d2.
Abstract | Full Text | PDF
We explored the associations between homocysteine, S-adenosylmethionine (SAM), and S-adenosylhomocysteine (SAH), total folate, 5-methyltetrahydrofolate (active folate, 5-MTHF), vitamin B12, vitamin B6, and endothelium-dependent flow-mediated vasodilation.  

 

Atherosclerosis & LipoproteinsBack

Kevin D. O’Brien, Thomas O. McDonald, Vidya Kunjathoor, KimLi Eng, Eleanor A. Knopp, Katherine Lewis, Roland Lopez, Elizabeth A. Kirk, Alan Chait, Thomas N. Wight, Frederick C. deBeer, and Renee C. LeBoeuf
Arterioscler Thromb Vasc Biol. 2005;25:785-790; published online before print February 3 2005, doi:10.1161/01.ATV.0000158383.65277.2b.
Abstract | Full Text | PDF
In chow-fed apoE-/- and LDLR-/- mice, serum amyloid A (SAA) is deposited at all stages of atherosclerotic lesion development and SAA immunoreactive area correlates highly with areas for lesions, apoA-I, apoB, and perlecan. These findings are consistent with the hypothesis that SAA may participate in atherosclerotic lesion lipoprotein retention.  

Charlotta Tenger, Anna Sundborger, Jacek Jawien, and Xinghua Zhou
Arterioscler Thromb Vasc Biol. 2005;25:791-796; published online before print December 16 2004, doi:10.1161/01.ATV.0000153516.02782.65.
Abstract | Full Text | PDF
To investigate whether cells other than T cells play a proatherogenic role via secretion of IFN-{gamma}, we used SCID/apoE knockout mice. Administration of IL-18 resulted in larger lesions and elevated IFN-{gamma}. Our data suggest that IFN-{gamma} from macrophages, NK cells, and vascular cells in vivo is sufficient for the disease progression.  

Jutta Belkner, Pavlos Chaitidis, Hannelore Stender, Christa Gerth, Ralf J. Kuban, Tanihiro Yoshimoto, and Hartmut Kuhn
Arterioscler Thromb Vasc Biol. 2005;25:797-802; published online before print January 27 2005, doi:10.1161/01.ATV.0000157580.26858.2d.
Abstract | Full Text | PDF
Lipoxygenases have been implicated in atherogenesis but their precise roles remain unclear. We tested the impact of 12/15-lipoxygenase on in vitro foam cell formation and found that the enzyme protected macrophages from intracellular lipid deposition. This effect was related to impaired scavenger receptor A expression and to accelerated lipid metabolism.  

Sharon L. Karackattu, Michael H. Picard, and Monty Krieger
Arterioscler Thromb Vasc Biol. 2005;25:803-808; published online before print February 3 2005, doi:10.1161/01.ATV.0000158310.64498.ac.
Abstract | Full Text | PDF | Data Supplement
SR-BI/apoE double knockout mice exhibit occlusive atherosclerotic coronary heart disease (CHD) characterized by myocardial infarctions, cardiac dysfunction, and premature death. Analysis of B-cell- and T-cell-deficient SR-BI/apoE/RAG2 triple knockout mice established that B and T lymphocytes do not play a key role in the pathophysiology of this model of human disease.  

Ulrich Laufs, Sven Wassmann, Thomas Czech, Thomas Münzel, Marco Eisenhauer, Michael Böhm, and Georg Nickenig
Arterioscler Thromb Vasc Biol. 2005;25:809-814; published online before print February 3 2005, doi:10.1161/01.ATV.0000158311.24443.af.
Abstract | Full Text | PDF | Data Supplement
Sedentary lifestyle predicts vascular risk. To study underlying mechanisms, mice were subjected to physical inactivity or voluntary training on running wheels. Inactivity increased vascular lipid peroxidation, superoxide release, and NADPH oxidase expression and activity. In apoE-/- mice, inactivity significantly impaired endothelium-dependent vasorelaxation and accelerated atherosclerotic lesion formation.  

Bente K. Kilhovd, Auni Juutilainen, Seppo Lehto, Tapani Rönnemaa, Peter A. Torjesen, Kåre I. Birkeland, Tore J. Berg, Kristian F. Hanssen, and Markku Laakso
Arterioscler Thromb Vasc Biol. 2005;25:815-820; published online before print February 3 2005, doi:10.1161/01.ATV.0000158380.44231.fe.
Abstract | Full Text | PDF
Serum levels of advanced glycation end products measured at baseline in a random sample of 1141 Finnish middle-aged nondiabetic individuals (535 men and 606 women) predicted all-cause mortality, cardiovascular, and coronary heart disease mortality after 18 years of follow-up in women but not in men.  

Miao-Pei Chen, Jack C.-R. Tsai, Fu-Mei Chung, Sheng-Shan Yang, Liang-Lan Hsing, Shyi-Jang Shin, and Yau-Jiunn Lee
Arterioscler Thromb Vasc Biol. 2005;25:821-826; published online before print February 3 2005, doi:10.1161/01.ATV.0000157784.25920.a7.
Abstract | Full Text | PDF
Adiponectin, an adipocyte-derived peptide with antiinflammatory and antiatherogenic effects, is known to protect against the initiation and progression of atherosclerosis. In this study, we investigate whether hypoadiponectinemia is present in patients with ischemic cerebrovascular disease (CVD). Our data show that there are significantly lower levels of plasma adiponectin in patients with ischemic CVD.  

Iina Volanen, Olli T. Raitakari, Raija Vainionpää, Martti Arffman, Johanna Aarnisalo, Susanna Anglé, Katariina Kallio, and Olli Simell
Arterioscler Thromb Vasc Biol. 2005;25:827-832; published online before print February 3 2005, doi:10.1161/01.ATV.0000158382.50942.6a.
Abstract | Full Text | PDF
Because infections have been associated with atherogenic lipid profiles in adults and because atherosclerotic process begins in early childhood, we examined whether Cpn, Hp, or CMV seropositivity is associated with serum lipids in otherwise healthy children. Antibody positivity correlated poorly with lipids, suggesting that other pathways link infection and early atherosclerosis.  

Pirkko J. Pussinen, Kristiina Nyyssönen, Georg Alfthan, Riitta Salonen, Jari A. Laukkanen, and Jukka T. Salonen
Arterioscler Thromb Vasc Biol. 2005;25:833-838; published online before print February 3 2005, doi:10.1161/01.ATV.0000157982.69663.59.
Abstract | Full Text | PDF
The association between serum antibody levels to periodontal pathogens and coronary heart disease (CHD) was analyzed in a prospective population-based study comprising 1023 men in the Kuopio Ischemic Heart Disease Study. High-serum antibody levels to major periodontal pathogens were associated with subclinical, prevalent, and future incidence of CHD.  

S. Matthijs Boekholdt, Tymen T. Keller, Nicholas J. Wareham, Robert Luben, Sheila A. Bingham, Nicholas E. Day, Manjinder S. Sandhu, J. Wouter Jukema, John J.P. Kastelein, C. Erik Hack, and Kay-Tee Khaw
Arterioscler Thromb Vasc Biol. 2005;25:839-846; published online before print February 3 2005, doi:10.1161/01.ATV.0000157933.19424.b7.
Abstract | Full Text | PDF
A prospective case-control study was performed to investigate the relationships between levels of secretory phospholipase A2 and the risk of coronary artery disease (CAD). Adjusted for traditional risk factors and C-reactive protein levels, the odds ratio for future CAD was 1.34 for people in the highest quartile (P for linearity=0.03).  

Elise Lavergne, Julien Labreuche, Mehdi Daoudi, Patrice Debré, François Cambien, Philippe Deterre, Pierre Amarenco, Christophe Combadière on Behalf of the GENIC Investigators
Arterioscler Thromb Vasc Biol. 2005;25:847-853; published online before print January 27 2005, doi:10.1161/01.ATV.0000157150.23641.36.
Abstract | Full Text | PDF
We analyzed the role of monocyte-recruiting chemokines in cerebrovascular diseases among the subjects of a case-control study of brain infarction (BI). Of the alleles tested, only homozygosity for the CX3CR1 rare alleles was associated with increased risk of BI. The associations may be related to CX3CL1-mediated monocyte adhesion.  

Francisco Rodríguez-Esparragón, José C. Rodríguez-Pérez, Yaridé Hernández-Trujillo, Antonio Macías-Reyes, Alfonso Medina, Araceli Caballero, and Carlos M. Ferrario
Arterioscler Thromb Vasc Biol. 2005;25:854-860; published online before print January 27 2005, doi:10.1161/01.ATV.0000157581.88838.03.
Abstract | Full Text | PDF | Data Supplement
HDL antioxidant properties have been attributed to the genetic-determined paraoxonase activity. Human scavenger receptor class B type 1 plays a central role in HDL-mediated cholesteryl ester hydroperoxides uptake. We tested for a significant contribution of these genes to coronary disease and analyzed the paraoxonase activity and CLA-1/SR-BI receptor functional properties.  

 

ThrombosisBack

Christine L. Kempton, Maureane Hoffman, Harold R. Roberts, and Dougald M. Monroe
Arterioscler Thromb Vasc Biol. 2005;25:861-866; published online before print January 13 2005, doi:10.1161/01.ATV.0000155987.26583.9b.
Abstract | Full Text | PDF
Platelets stimulated with convulxin plus thrombin compared with thrombin alone develop a subpopulation with increased surface binding of FV, VIII, IX, and X that is dependent on the concentration of convulxin and is correlated with increases in factor Xa and thrombin generation. These findings suggest that the proportion of platelets in the high-binding subpopulation regulates the degree of thrombin generation in the presence of convulxin.  

Suzanne J.A. Korporaal, Gertie Gorter, Herman J.M. van Rijn, and Jan-Willem N. Akkerman
Arterioscler Thromb Vasc Biol. 2005;25:867-872; published online before print February 3 2005, doi:10.1161/01.ATV.0000158381.02640.4b.
Abstract | Full Text | PDF | Data Supplement
OxLDL modulates platelet function via distinct mechanisms. At <15% oxidation, agonist-induced platelet functions are enhanced through activation of a p38MAPK-mediated pathway. At >30% oxidation, oxLDL induces LPA-dependent Ca2+ mobilization, leading to immediate aggregation. At >15% oxidation, p38MAPK-induced sensitization disappears and oxLDL inhibits agonist-induced platelet functions by binding to CD36, thereby interfering with {alpha}IIbß3-mediated outside-in signaling.  

 

Special ReportsBack

Clinical Trial Registration: A Statement From the International Committee of Medical Journal Editors

Catherine De Angelis, Jeffrey M. Drazen, Frank A. Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marusic, A. John P.M. Overbeke, Torben V. Schroeder, Hal C. Sox, and Martin B. Van Der Weyden
Arterioscler Thromb Vasc Biol. 2005;25:873-874, doi:10.1161/01.ATV.0000162428.48796.22.
Full Text | PDF  

 

Letters to the EditorBack

Rho Kinase Inhibition and Vascular Protection: Support From Studies in Bartter and Gitelman Syndrome

Lorenzo A. Calò, Elisa Pagnin, Paul A. Davis, Michelangelo Sartori, Andrea Semplicini, Achille C. Pessina, Sebastian Wolfrum, Yoshiyuki Rikitake, James K. Liao, Andreas Dendorfer, Peter Dominiak, Timothy J. Stalker, Yulan Gong, and Rosario Scalia
Arterioscler Thromb Vasc Biol. 2005;25:e34-e35, doi:10.1161/01.ATV.0000153089.74997.02.
Full Text | PDF  

Association Between IL-1ß Gene Polymorphism and Myocardial Infarction

Yukihiko Momiyama, Reiko Ohmori, and Fumitaka Ohsuzu
Arterioscler Thromb Vasc Biol. 2005;25:e36, doi:10.1161/01.ATV.0000159700.18731.d2.
Full Text | PDF  

Oxidative Stress, Antioxidants, and Cardiovascular Disease

F. Violi, R. Cangemi, A. Brunelli, Nageswara R. Madamanchi, and Marschall Runge
Arterioscler Thromb Vasc Biol. 2005;25:e37, doi:10.1161/01.ATV.0000159889.32537.43.
Full Text | PDF  

 

CorrectionsBack

Correction


Arterioscler Thromb Vasc Biol. 2005;25:875.
Full Text | PDF  

Correction


Arterioscler Thromb Vasc Biol. 2005;25:875a.
Full Text | PDF  

Spotlight

TOC Spotlight File Banner1TOCpage

Banner2TOCpage